Hva er Crescat?Crescat er systemet som hjelper deg med planlegging og gjennomføring av arrangementer. Samarbeid enkelt med alle, i ett og samme system. Crescat er utviklet i tett samarbeid med kulturbransjen. Våre kunder er arrangører, eventbyrå, scener og kulturhus. Vi jobber for å gjøre kundens hverdag enklere. Hvem er vi?Crescat er gründerbedrift i vekst, med utspring i Bergen. Vi holder til midt i Bergen sentrum i topp moderne lokaler. Crescat-teamet består idag av et knippe inspirerte og hardtarbeidende mennesker. Vi har et ungt og dynamisk miljø, og vi har et sterkt fokus på at alle skal trives og ha det gøy på jobb.

E24 er en del av Schibsted, og eies i fellesskap av VG, Aftenposten, Bergens Tidende og Stavanger Aftenblad. Med 1,5 millioner unike brukere hver uke, over halvparten på mobil, er vi Norges desidert største nettavis for økonomi og næringsliv. Høsten 2019 varslet vi en offensiv oppbemanning og nytt samarbeid på tvers i Schibsted, for å ta en enda sterkere og tyngre posisjon. Vi gir deg det aller siste fra aksjemarkedet, og tar pulsen på norsk og internasjonal økonomi, pluss nyheter fra felter som IT, ledelse, energi og bil.

Cavai AS was founded in December 2017 with the goal of revolutionizing online advertising. User experiences have largely been neglected on the web, and Cavai saw early on that chatbot technology, which has initially been used in customer service, could be a wonderfully good advertising product. Usually, chatbot technology is used as customer service on its own website, while Cavai's platform is built to be able to use chatbot technology on millions of websites for contextual advertising. The team today consists of 15 people, and the product has been launched in Norway, Finland, Sweden and the UK with 50 paying customers. Customers are very pleased and report that Cavai's technology is having a very good effect on completed advertising campaigns. Cavai will have its first month of positive operating results in October and looks to have sales of around 3 million in 2019. Next year will be a big growth year, where we have budgeted with a turnover of NOK 41 million. This growth has also been discussed by Finansavisen, where as part of Finansavisen's web-TV series "Vext", Cavai filmed his meeting with advertising legend Sir Marting Sorell in London. For more information, see https://finansavisen.no/vext/tech/2019/10/23/7465643/chatbot-company-cavai-2020-blir-the-store-growst>  To finance further growth, we are now running a seed funding round of NOK 9.5 - 15 million. The company is priced at NOK 60 million pre-money. For more information see the investor summary, investor presentation and subscription form attached.

Novelty Food was established to promote great-tasting gifts for the premium market. Our basic philosophy is to create products that are tempting enough for you to buy the first time, and tasty enough for you to want to buy again. Novelty Food er et utviklings-, salgs, og markedsselskap for premium produkter. Vi har en stabil og god salgsbase i Norge med salg til både Norgesgruppen, Sunkost og Tax Free butikkene. Vi har i tillegg flere internasjonale partnere – blant annet Disney World og EPCOT, hvor Grieg Suites er valgt som den norske sjokoladen for salg.

Med-Storm's Skin Conductance Algesimeter (SCA) uses the principle of skin conductance to measure pain, allowing us to titrate the right amount of pain medication for each, individual patient. This award-winning technology is not affected by changes in blood circulation, heart rate, hypotensia, environmental temperatures, and hypoxia, and shows low variation between individuals at the same level of pain. The pain monitor can be used on patients as young as 23 weeks of gestational age, as well as geriatric patients. MS is currently working on a miniaturized and wireless version of the SCA.

Bygg- og anleggsbransjen er en lite digitalisert bransje per dags dato. NAEVA setter fokus på mer enn digitalisering. Vi ønsker i tillegg å effektivisere og automatisere hverdagen.Ved å kombinere de beste menneskene med nyskapende teknologi og innovative løsninger, ønsker vi å skape fremtidens bygg- og anleggsbransje i dag. Vi har vårt utgangspunkt i bygg- og anleggsbransjen, men våre løsninger kan skreddersys de fleste bransjer og industrier.

SandTools AS: Hardware Innovation & Sales company.Work Ethics: Verified steps. Hope is not a strategy. We are developing an intelligent Construction & Landscaping tool for international sales. Functioning prototype 5 has been tested in Norway, Sweden, and Denmark. Freedom to Operate and IPR is secured (WIPO Industrial Design)Market research tells a good story, with a 75% score among relevant users in the EU. Relevant users were found through a joint effort with SSB and Eurostat. The market's demand ratio of 75% forecasts actual sales of 5-20%. Preordering has started—the first investor (Jetro AS) is in place regarding Electronic Product Development. We are looking for Investor/partner for production and sales kick-off.

Today, legal services are provided on the premises of the legal industry. We believe in making legal services available to everyone. We do this by automating legal processes by connecting law with design and technology. So that more people are able to be their own lawyers. We are testing our solutions in the Norwegian market at the moment, but all services are built to scale internationally. Stay tuned to receive more info when the legal products built to provide access to justice is ready to launch.

Estro has developed a patented solution to improve Fish Health for Norwegian and International Fish farms, the "SeaNest" solution reduce mortality, and facilitate and improve the working environment for both farmer and Fish. A controllable solution for the clean Fish in the Battle against the lice, zero contamination, and no loose parts eliminate the risk of pollution. Easy to Wash and handle. We have signed a full-scale test program with some of the largest companies within the business, and so far with a positive result. First Emission fulfilled mid of 2018, and the commercialization process started.

Demand for peronal-safe biometric-IDs. If connected you can be hacked and if your IDs are stolen you are digitally-dead. Mobiles and web surveillance are recording our face, fingers and iris pictures. IDs for banking, trade and health must be separated from all the data stored at big-data, governments, secret-services, criminals and social medias. As it is not possible to secure our biometric-IDs 100% we just make stealing IDs not worthwhile. How do we do that? With Cybi-key create your safe Cyber-biometric-IDs from our digital twins. Cybi-IDs the trusted id payment missing today.

Monio AS (org. nr. 913 978 617) er et heleid datterselskap av SpareBank 1 SR-Bank ASA (org. nr. 937 895 321). Monio AS formidler lån til små og mellomstore bedrifter og er regulert av Finanstilsynet med tillatelse til å drive virksomhet som betalingsforetak og er registrert som låneformidler. Som lånformidler er Monio ikke en part i låneavtalen mellom långiver og låntaker.

Moderne Media ble startet med et ønske om å formidle gode historier. Det er fortsatt kjerneverdien i alt vi gjør. Med podkast, TV, film, reklame og sosiale medier, har vi flere muligheter enn noen gang til å produsere og dele gode historier.Folkene du møter i Moderne Media jobber med det de synes er morsomst, og det de er flinkest til. Vi har oppdaget at de to tingene har en sammenheng. Derfor prøver vi å rendyrke personligheter og individer.

Oncoinvent AS is a privately held Norwegian company established in 2010. The company is committed to developing new innovative products to provide better treatment options to cancer patients. The innovations being developed by Oncoinvent AS are a result of the extensive experience with the development of radionuclide-based cancer treatments of two of the founders, Dr. Roy H. Larsen and Professor of clinical oncology Øyvind S. Bruland. Larsen and Bruland are the inventors of the first FDA and EMA-approved alpha-emitting pharmaceutical product Xofigo® (Bayer AG), as well as of the beta-emitting radio-immunotherapeutic product candidate Betalutin® (Nordic Nanovector ASA). Oncoinvent's lead product candidate, Radspherin®, is a novel alpha-emitting radioactive microsphere designed for the treatment of metastatic cancers in body cavities. Radspherin® has been shown to cause a significant reduction in tumor cell growth. It is anticipated that the product can potentially treat several forms of metastatic cancer. The first clinical indication for Radspherin® will be the treatment of peritoneal carcinomatosis. Clinical development will be conducted in collaboration with European and American clinical research centers.

RESPINOR is a privately-owned medical device company, founded in Oslo, 2015. We have developed an objective measure of breathing for critically ill patients within intensive care. The technology provides precise, continuous and real-time information of diaphragm function, our main breathing muscle, to increase the quality of care and reducing costs. RESPINOR’s technology is the winner of Horizon 2020 both in phase I and II. We are addressing an unmet medical need because every breath counts.

Yetz is a new distribution platform for product lines such as insurance, electricity, telecom, and finance. At launch, we will offer both insurance and power. We utilize strong incentives towards our customers and partners to share the concept, by giving them an affiliate commission. Monthly payment is based on the turnover of customers they have referred. Two fully owned sister companies Yetz Strøm og Yetz Forsikring.